Ganciclovir API (CAS No. 82410-32-0) is a synthetic antiviral nucleoside analogue pharmaceutical active ingredient associated with cytomegalovirus (CMV) treatment and prevention applications. Ganciclovir is an acyclic guanine nucleoside analogue and belongs to the class of antiviral agents that inhibit viral DNA replication.
Following intracellular phosphorylation, Ganciclovir is converted to its active triphosphate form. Ganciclovir triphosphate inhibits viral DNA polymerase and interferes with viral DNA synthesis, thereby reducing replication of susceptible cytomegalovirus.
Pharmaceutical companies sourcing Ganciclovir API commonly evaluate assay, HPLC purity, related substances, process-related impurities, degradation products, residual solvents, water content, crystalline characteristics, particle size distribution, and batch-to-batch consistency.
Impurity-profile control is an important consideration during Ganciclovir API qualification. Pharmaceutical buyers may evaluate guanine-related impurities, process intermediates, degradation products, chromatographic purity, residual solvents, and consistency of the API physical characteristics according to the applicable pharmacopoeial or approved product specification.
Ganciclovir is a polar hydrophilic pharmaceutical compound with limited aqueous solubility. Particle size distribution and crystalline characteristics may therefore be evaluated according to the intended formulation process and dosage-form requirements.
Swapnroop Drugs and Pharmaceuticals supplies Ganciclovir API for qualified pharmaceutical research, formulation development, analytical, generic drug development, and regulated manufacturing requirements with product-specific quality documentation, pharmaceutical-grade packaging, and reliable supply-chain coordination.
Ganciclovir API is primarily associated with:
Ganciclovir is associated with pharmaceutical products used for the treatment of CMV retinitis in immunocompromised adults and prevention of CMV disease in adult transplant recipients at risk of CMV disease.
Ganciclovir is an antiviral nucleoside analogue associated with inhibition of cytomegalovirus DNA replication.
Pharmaceutical formulation companies evaluating Ganciclovir API may review:
Product-specific API specifications should be evaluated according to the intended dosage form, target regulatory market, formulation technology, and approved pharmaceutical development requirements.
Ganciclovir is an established antiviral active pharmaceutical ingredient associated with cytomegalovirus pharmaceutical applications.
The antiviral activity of Ganciclovir is linked to its intracellular conversion to Ganciclovir triphosphate. The active triphosphate metabolite inhibits viral DNA polymerase and interferes with viral DNA synthesis.
Pharmaceutical companies developing Ganciclovir formulations may evaluate API purity, impurity profile, physical characteristics, and formulation compatibility to support consistent drug-product manufacturing.
Ganciclovir and Ganciclovir Sodium should be evaluated according to the exact required pharmaceutical material and formulation application.
Ganciclovir API has CAS No. 82410-32-0, molecular formula C9H13N5O4, and molecular weight 255.23 g/mol.
Ganciclovir for injection may be formulated through neutralization of Ganciclovir with sodium hydroxide to form the monosodium salt in the drug-product manufacturing process.
Procurement, formulation, quality, and regulatory teams should confirm the exact required material specification before commercial sourcing.
Swapnroop Drugs and Pharmaceuticals supports qualified pharmaceutical and research customers with:
Ganciclovir API is supplied in secure pharmaceutical-grade packaging selected according to product quantity, stability requirements, moisture protection requirements, and customer specifications.
Product-appropriate inner polyethylene liners and approved pharmaceutical-grade outer containers or HDPE drums may be used according to the supplied material specification.
Available packaging configurations may include:
Packaging configuration, MOQ, commercial quantity, particle size requirements, and shipment conditions are confirmed according to the approved product specification and customer enquiry.
Store Ganciclovir API in tightly closed and appropriately labeled containers under recommended controlled storage conditions.
Protect the material from excessive moisture, heat, direct light, and unsuitable environmental exposure.
Ganciclovir requires appropriate occupational handling controls. Handling should be performed by trained personnel using approved pharmaceutical material procedures, suitable containment practices, and applicable safety documentation.
Product-specific storage and handling requirements should be confirmed from the approved COA, SDS, specification, and stability documentation.
Swapnroop Drugs and Pharmaceuticals provides Ganciclovir API bulk supply and export support in India for qualified pharmaceutical manufacturers, antiviral formulation developers, generic drug companies, analytical laboratories, research organizations, and pharmaceutical procurement customers.
For Ganciclovir API price, CAS No. 82410-32-0, USP specification, HPLC purity, particle size requirements, COA availability, MOQ, packaging, and export enquiries, contact our pharmaceutical sales team.
Get Bulk Quote via WhatsApp